SightfileU.S. market data from official filings

NATURES SUNSHINE PRODS INC (NATR)

Name: NATURES SUNSHINE PRODS INC (NATR) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000275053 · EDGAR filings · Updated 2026-06-29

NATURES SUNSHINE PRODS INC (NATR) has reported institutional ownership of 87.1%, with 152 institutional managers holding positions valued at $367.5M per the latest 13F reporting period.

Institutional ownership

87.1%

Institutional managers

152

Reported 13F value

$367.5M

Insider activity

97 trans.

−$34.5M net selling

Latest updates

2026-06-29 — Insider transaction reported (Form 4)
2026-06-15 — Insider transaction reported (Form 4)
2026-06-11 — Insider transaction reported (Form 4)
2026-06-03 — Insider transaction reported (Form 4)
2026-05-22 — Insider transaction reported (Form 4)
2026-05-20 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NATURES SUNSHINE PRODS INC has 152 institutional holders and institutional ownership of 87.1%.

Insider activity

Insiders reported 97 transactions (0 buys, 12 sells) across 21 reporting insiders, with a net reported value of −$34.5M.

Related companies

ASSEMBLY BIOSCIENCES INC (ASMB) · X4 PHARMACEUTICALS INC (XFOR) · CYTEK BIOSCIENCES INC (CTKB) · SHATTUCK LABS INC (STTK) · EMERGENT BIOSOLUTIONS INC (EBS) · ANTERIS TECHNOLOGIES GLOBAL (AVR)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-29.